Literature DB >> 20124617

Deep vein thrombosis in acute myelogenous leukemia.

Amaylia Oehadian1, Mohammad Iqbal, Rachmat Sumantri.   

Abstract

Thrombotic complications in acute leukemia are often underestimated because bleeding complications generally dominate the clinical picture. While there are many thrombogenic factors shared by both solid tumors and leukemia, many additional prothrombotic features are present in leukemia. The prothrombotic factors include hyperleukocytosis, increased expression of tissue factor and its activation in leukemic cells, and the prothrombotic adverse effects of therapeutic agents and vascular access cathethers. A 18-year old woman came with swelling on her right leg 10 days before hospital admission. Since 2 months before she had had weakness, pallor and fever without bleeding manifestation. Hematologic examinations showed anemia, leukocytosis with monoblast and thrombocytopenia. Deep vein thrombosis in right femoral and right popliteal vein was confirmed using compression ultrasonography. The treatment of such complications is challenging because of the high risk of hemorrhage in this group of patients, especially due to their severe thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20124617

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  2 in total

1.  Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.

Authors:  Garth W Tormoen; Olivia Recht; András Gruber; Ross L Levine; Owen J T McCarty
Journal:  Phys Biol       Date:  2013-10-08       Impact factor: 2.583

2.  Whole blood viscosity issues VII: The correlation with leucocytosis and implication on leukapheresis.

Authors:  Ezekiel Uba Nwose; Ross Stuart Richards
Journal:  N Am J Med Sci       Date:  2010-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.